STOCK TITAN

Allied (ALID) Financials

ALID
FY2024 annual
Revenue $96K +33.4% YoY
Net Income -$4.0M YoY not available
EPS (Diluted) -$0.04 YoY not available
Free Cash Flow -$2.0M +1.8% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2025, ended Nov 30, 2024 Reported Currency USD FYE August

Newest figures come from the 10-Q for Q1 FY2025, filed Jan 14, 2025. Each column of the statement tables below links to the filing it was taken from.

Allied (ALID) reported $96K in revenue for fiscal year 2024, up 33.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALID FY2024

Allied's operating model remains cash-consuming and obligation-heavy, with financing inflows offsetting losses rather than funding substantial reinvestment.

In FY2024, operating cash flow was -$2.0M while financing cash flow supplied $2.2M, indicating that external financing offset the cash cost of operations. Free cash flow was also -$2.0M despite only $2K of capital spending, so the cash requirement was operating rather than reinvestment-heavy.

By FY2024, liabilities were $9.7M against assets of $2.1M, leaving negative equity; the balance sheet is financed primarily by obligations rather than operating assets. A current ratio of 0.1x and reported liquidity of 2.2 months describe very limited short-term coverage relative to the latest annual operating outflow.

Revenue fell from $166K in FY2022 to $96K in FY2024, while gross margin ended negative; lower volume did not restore direct-cost coverage. Operating margin improved from -89.2% to -41.3%, but remained deeply negative, making the change a reduction in loss intensity rather than evidence of a viable margin structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Allied does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-43.92

Allied scores -43.92, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.3M) relative to total liabilities ($9.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/7

Allied passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Allied reported a net loss of $4.0M while operations used $2.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Allied reported an operating loss of $4.0M against $472K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$28K
YoY+45.3%

Allied generated $28K in revenue in Q1 2025. This represents an increase of 45.3% from the same quarter a year earlier.

EBITDA
-$575K
YoY+24.0%

Allied's EBITDA was -$575K in Q1 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 24.0% from the same quarter a year earlier.

Net Income
-$780K
YoY+6.7%

Allied reported -$780K in net income in Q1 2025. This represents an increase of 6.7% from the same quarter a year earlier.

EPS (Diluted)
-$0.01
YoY0.0%

Allied earned -$0.01 per diluted share (EPS) in Q1 2025. That is unchanged from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow
-$547K
YoY-17.2%
QoQ+10.8%

Allied recorded an outflow of $547K in free cash flow in Q1 2025, representing a cash shortfall after capex. This represents a decrease of 17.2% from the same quarter a year earlier. Against the prior quarter it is up 10.8%.

Cash & Debt
$195K
YoY+393.4%
QoQ-45.6%
5Y CAGR-11.5%
10Y CAGR+43.3%

Allied held $195K in cash as of Q1 2025; long-term debt is not reported for that period.

Shares Outstanding
115M
YoY+13.4%
QoQ0.0%
5Y CAGR+6.9%
10Y CAGR+24.4%

Allied had 115M shares outstanding in Q1 2025. This represents an increase of 13.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2025.

Margins & Returns

Gross Margin
49.2%
YoY-40.3pp

Allied's gross margin was 49.2% in Q1 2025, indicating the percentage of revenue retained after direct costs. This is down 40.3 percentage points from the same quarter a year earlier.

Operating Margin

Not shown for Q1 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q1 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q1 2025.

Capital Allocation

Capital Expenditures
$37K
QoQ+5557.2%

Allied invested $37K in capex in Q1 2025, funding long-term assets and infrastructure. Against the prior quarter it is up 5557.2%.

R&D Spending

Not reported for Q1 2025.

Share Buybacks

Not reported for Q1 2025.

ALID Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALID quarterly income statement
MetricQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$28K+45.3%N/A$77K$0$19K-72.7%N/A$0-100.0%$0-100.0%
Cost of Revenue$14K+601.8%N/A$22K$0$2K-92.3%N/A$0-100.0%$0-100.0%
Gross Profit$14K-20.1%N/A$55K$0$17K-61.0%N/A$0+100.0%$0+100.0%
R&D ExpensesN/AN/AN/AN/AN/AN/A$0$0-100.0%
SG&A Expenses$208K+36.3%N/A$324K+1.1%$33K-96.3%$153K+118.3%N/A$321K+32.3%$887K+120.3%
Operating Income-$609K+23.1%N/A-$795K+61.6%-$773K+60.9%-$792K+34.0%N/A-$2.1M+10.9%-$2.0M+8.1%
EBITDA-$575K+24.0%N/A-$760K+62.7%-$746K+61.7%-$757K+35.5%N/A-$2.0M-$1.9M+7.1%
Interest Expense$123K+32.4%N/A$96K+2.5%$93K+5.9%$93K+11.6%N/A$94K+25.4%$88K-26.9%
Net Income-$780K+6.7%N/A-$891K+58.8%-$866K+58.1%-$837K+36.1%N/A-$2.2M+18.1%-$2.1M+11.2%
EPS (Diluted)-$0.010.0%N/AN/AN/A-$0.01N/AN/AN/A
Diluted Shares (Avg)113M+10.3%N/AN/AN/A103MN/AN/AN/A

Not reported in any period shown, so not listed: Income Tax, EPS (Basic).

ALID Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALID quarterly balance sheet
MetricQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Total Assets$2.0M-2.9%$2.1M+2.5%$2.2M-64.5%$2.3M-62.5%$2.0M-65.9%$2.1M-64.4%$6.2M+21.9%$6.1M+9.0%
Current Assets$612K+33.1%$714K+51.6%$717K-59.9%$767K-54.9%$460K-67.9%$471K-62.1%$1.8M+411.8%$1.7M+77.5%
Cash & Equivalents$195K+393.4%$359K+71.2%$92K+2504.8%$102K-38.4%$40K-66.4%$210K+118.4%$4K-95.6%$165K-73.3%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$287K+16.7%$261K+142.8%$343K-79.0%$444K-68.1%$246K-79.3%$108K-89.2%$1.6M+609.6%$1.4M+709.8%
Accounts Receivable$76K$48K-64.3%N/AN/AN/A$134KN/AN/A
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$9.6M+283.1%$9.7M+300.5%$9.9M+14.6%$9.8M+20.3%-$5.2M-170.9%-$4.8M-168.2%$8.6M+23.1%$8.2M+35.1%
Current Liabilities$9.5M+3.6%$9.5M+7.9%$9.8M+15.4%$9.7M+21.2%$9.2M+26.4%$8.8M+28.1%$8.5M+24.6%$8.0M+37.3%
Non-Current Liabilities$104K+100.7%$115K+100.8%$95K-33.6%$96K-29.7%-$14.4M-10056.7%-$13.7M-8405.2%$143K-29.1%$137K-31.2%
Long-Term DebtN/A$101KN/AN/AN/AN/AN/AN/A
Total Equity-$7.6M-205.4%-$7.5M-209.6%-$7.7M-220.2%-$7.5M-267.2%$7.2M+584.2%$6.9M+636.8%-$2.4M-26.4%-$2.1M-373.7%
Retained Earnings-$50.4M-8.4%-$49.6M-8.7%-$48.2M-19.1%-$47.3M-23.5%-$46.4M-28.2%-$45.6M-30.6%-$40.5M-17.5%-$38.3M-20.5%

Not reported in any period shown, so not listed: Goodwill.

ALID Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALID quarterly cash flow statement
MetricQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Operating Cash Flow-$509K-9.2%-$612K-1247.6%-$443K-55.7%-$478K+57.7%-$466K+21.7%$53K+105.2%-$285K+64.7%-$1.1M-53.9%
Depreciation & Amortization$33K-5.9%$42K-9.5%$36K+5.8%$27K-13.2%$35K+35.4%$46K$34K$31K-44.9%
Stock-Based Compensation$54K-62.5%N/A$105K-93.9%$223K-61.1%$144K-73.6%N/A$1.7M+68.2%$574K-18.3%
Capital Expenditures$37K-$661-58.8%$672-5.2%$2K-86.1%$0-100.0%$2K$709$15K
Free Cash Flow-$547K-17.2%-$613K-1284.4%-$444K-55.6%-$480K+58.0%-$466K+29.6%$52K-$285K-$1.1M
Investing Cash Flow-$37K-$828+63.4%-$525+26.0%-$9K+54.1%$0+100.0%-$2K-108.5%-$709+99.7%-$19K+96.9%
Financing Cash Flow$381K+10.1%$748K+34.7%$420K+52.7%$646K+24.0%$346K-51.8%$555K-48.6%$275K-52.6%$521K-68.8%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ALID Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALID quarterly financial ratios
MetricQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Gross Margin49.2%-40.3ppN/A71.9%N/A89.5%+26.8ppN/AN/AN/A
Operating Margin-2200.4%N/A-1031.2%N/A-4160.6%N/AN/AN/A
Net Margin-2820.1%N/A-1155.6%N/A-4394.5%N/AN/AN/A
Return on EquityN/AN/AN/AN/A-11.5%N/AN/AN/A
Return on Assets-40.0%+1.6ppN/A-40.3%-5.6pp-37.8%-4.0pp-41.6%-19.4ppN/A-34.8%+17.0pp-33.8%+7.7pp
Current Ratio0.060.0x0.070.0x0.07-0.1x0.08-0.1x0.05-0.1x0.05-0.1x0.21+0.2x0.210.0x
Asset Turnover0.010.0xN/A0.030.0x0.000.0x0.010.0xN/A0.000.0x0.000.0x
FCF Margin-1975.3%N/A-575.3%N/A-2449.6%N/AN/AN/A

Not reported in any period shown, so not listed: Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$7.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Allied ALID FY2024 $96K -$4.0M N/A $1.3M
Panacea Life Sciences Hldgs Inc PLSH FY2023 $2.4M -$8.0M N/A $2.1M
Acura Pharm ACUR FY2021 $1.6M -$879K -56.2% $7K

Frequently Asked Questions

What is Allied's annual revenue?

Allied (ALID) reported $96K in total revenue for fiscal year 2024. This represents a 33.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Allied's revenue growing?

Allied (ALID) revenue grew by 33.4% year-over-year, from $72K to $96K in fiscal year 2024.

Is Allied profitable?

No, Allied (ALID) reported a net income of -$4.0M in fiscal year 2024.

Allied (ALID) reported diluted earnings per share of -$0.04 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Allied (ALID) had EBITDA of -$3.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2024, Allied (ALID) had $359K in cash and equivalents against $101K in long-term debt.

Allied (ALID) recorded an outflow of $2.0M in free cash flow during fiscal year 2024. This represents a 1.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Allied (ALID) recorded an outflow of $2.0M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

Allied (ALID) had $2.1M in total assets as of fiscal year 2024, including both current and long-term assets.

Allied (ALID) invested $2K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Allied (ALID) had 115M shares outstanding as of fiscal year 2024.

Allied (ALID) had a current ratio of 0.07 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

Allied (ALID) had a return on assets of -188.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2024, Allied (ALID) held $359K in cash, cash equivalents and investments, and reported an operating cash outflow of $2.0M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Allied (ALID) has negative shareholder equity of -$7.5M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Allied (ALID) has an Altman Z-Score of -43.92, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Allied (ALID) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Allied (ALID) reported a net loss of $4.0M while operations used $2.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Allied (ALID) reported an operating loss of $4.0M against $472K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top